Immunocore
IMCR
$58.46
Share price
0.79%
Change (1 day)
-1.88%
Change (1 year)
Categories
Operating Margin for Immunocore (IMCR)
Operating Margin as of April 2024 (TTM): -21.82%
According to Immunocore's latest financial reports and stock price the company's current Operating Margin is -21.82%. At the end of 2022 the company had an Operating Margin of -30.71%.
Operating Margin history for Immunocore from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -30.71% | -94.22% |
| 2021 | -531.40% | 83.18% |
| 2020 | -290.10% | -40.99% |
| 2019 | -491.60% | 31.87% |
| 2018 | -372.78% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.